| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |